Samarra medicines intends to produce new products for the first time in Iraq
09:32 - 09/01/2020
[You must be registered and logged in to see this link.]
The General Company for the manufacture of medicines and medical supplies in Samarra, one of the companies of the Ministry of Industry and Minerals, announced on Thursday that it achieved a significant increase in the value of production during the second half of last year 2019, with a development rate of (46%) over the production value for the first half of the year The same, while confirming its intention to make new products for the first time in the country.
The general manager of the pharmaceutical company, Abdel Hamid Abdel Rahman Al Salem, said in a statement that he received / the information, a copy of it, “The company was able to double its production in the second half of last year, achieving a production value of (24) billion and (416) million dinars, and with a percentage of development ( 46%) compared to (16) billion and (718) million dinars achieved in the first half of the same year.
Al-Salem added, "The development is a result of the concerted efforts of all the company's departments and the availability of raw materials in addition to the implementation of plans and production programs that in turn led to development and increase in production."
He pointed out, "The company seeks to set ambitious production plans for the current year 2020 and the coming years and try to operate most of the stalled production lines and produce new products for the first time in the country to secure the need of the Iraqi individual of the various products produced by the company that match foreign pharmaceuticals and are characterized by their high efficiency and quality and their prices appropriate to the level of citizen income Iraqi. ” Ended / 25